Clinical Assessment & Protocol
Typical Presentation (HPI)
EN: Patient found unconscious with severe vomiting and abdominal pain. AR: مريض وجد فاقداً للوعي مع قيء شديد وألم في البطن.
General Examination
EN: Garlic odor on breath, QTc prolongation on ECG. AR: رائحة ثوم في النفس، وإطالة فترة QTc في تخطيط القلب.
Treatment Protocol
EN: AR:
Patient Education
EN: AR:
Systemic & Specialized Examinations
EN: S1, S2 present. No murmurs. AR: صوتا القلب الأول والثاني طبيعيان. لا توجد نفخات.
EN: Lungs clear to auscultation. AR: الرئتان صافيتان عند التسمع.
EN: Abdomen soft, non-tender. AR: البطن لين ولا يوجد ألم.
EN: Alert, oriented x3. No focal deficits. AR: المريض واعي ومدرك. لا يوجد عجز عصبي بؤري.
EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.
EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.
EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.
EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.
EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.
Orthopedic & Trauma Assessments
EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.
EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.
1. Comprehensive Introduction & Overview
Acute arsenic poisoning is a life-threatening medical emergency resulting from the ingestion, inhalation, or dermal absorption of toxic quantities of arsenic compounds. Arsenic is a naturally occurring metalloid found in the earth's crust, often associated with industrial processes, pesticides, mining, and contaminated water supplies. While chronic arsenic exposure (arsenicosis) is a well-documented public health crisis globally, acute poisoning remains a critical toxicological challenge characterized by rapid multi-organ failure.
The clinical profile of acute arsenic poisoning is notorious for its insidious onset and its ability to mimic common gastrointestinal ailments before progressing to fulminant cardiovascular collapse, encephalopathy, and multi-organ dysfunction syndrome (MODS). Due to its historical use as a homicidal agent and its presence in various industrial chemical precursors, clinicians must maintain a high index of suspicion in cases of unexplained severe gastroenteritis, particularly when accompanied by cardiac arrhythmias or neurological decline.
2. Etiology and Pathophysiology
Etiological Factors
Arsenic exists in three primary forms, each with varying degrees of toxicity:
* Inorganic Arsenic (Trivalent, As3+): Arsenite compounds (e.g., arsenic trioxide) are significantly more toxic than pentavalent forms.
* Inorganic Arsenic (Pentavalent, As5+): Arsenate compounds.
* Organic Arsenic: Generally considered less toxic; found in certain seafood (arsenobetaine), though these are typically excreted rapidly without clinical sequelae.
Mechanisms of Action
The pathophysiology of arsenic toxicity centers on its high affinity for sulfhydryl (-SH) groups.
1. Enzyme Inhibition: Arsenite binds to the sulfhydryl groups of lipoic acid, a critical cofactor for the pyruvate dehydrogenase complex. This effectively shuts down the citric acid cycle (Krebs cycle) and inhibits cellular respiration.
2. ATP Depletion: By uncoupling oxidative phosphorylation, arsenic prevents the synthesis of Adenosine Triphosphate (ATP), leading to immediate cellular energy crisis.
3. Oxidative Stress: Arsenic induces the production of reactive oxygen species (ROS), causing lipid peroxidation, DNA damage, and subsequent apoptosis.
4. Vascular Endothelial Damage: The toxin causes direct damage to the vascular endothelium, leading to increased capillary permeability, profound fluid loss, and distributive shock.
3. Clinical Staging and Presentation
Clinical progression is typically divided into three distinct phases following a significant ingestion.
| Phase | Timing | Clinical Manifestations |
|---|---|---|
| Phase 1: Gastrointestinal | 30 min – 4 hours | Severe vomiting, "rice-water" stools (cholera-like), abdominal pain, hematemesis. |
| Phase 2: Latent/Cardiovascular | 4 – 24 hours | Hypotension, tachycardia, QT prolongation, ventricular arrhythmias, dehydration. |
| Phase 3: Multi-organ Failure | 24+ hours | Encephalopathy, renal failure (ATN), hepatic necrosis, bone marrow suppression. |
Standard Presentation
- Gastrointestinal: The hallmark of acute ingestion is profuse, watery diarrhea that may become bloody. The extreme fluid loss often leads to severe hypovolemic shock.
- Dermatological: In cases of dermal exposure, localized dermatitis may occur. In acute systemic poisoning, Mees' lines (transverse white bands on fingernails) may appear weeks later, though they are more characteristic of chronic exposure.
- Neurological: Patients often present with extreme agitation, confusion, or seizures, progressing to coma as cerebral edema develops.
4. Differential Diagnosis
Because of its non-specific early presentation, acute arsenic poisoning is frequently misdiagnosed. Clinicians must consider:
* Cholera: Due to the severity of watery diarrhea.
* Acute Gastroenteritis (Viral/Bacterial): Common, but usually lacks the rapid progression to multi-organ failure.
* Organophosphate Poisoning: Often presents with cholinergic crisis (SLUDGE syndrome), which differs from the arsenic profile.
* Heavy Metal Toxicity: Lead, mercury, or thallium poisoning, which share some neurological and gastrointestinal features.
* Acute Myocardial Infarction: Given the ECG changes (QT prolongation) often seen in arsenic toxicity.
5. Diagnostic Testing and Evaluation
A high index of suspicion is the most critical diagnostic tool. Laboratory confirmation is often retrospective, but immediate testing is essential for supportive care.
Key Diagnostic Tests
- Urinary Arsenic Levels: The gold standard. A 24-hour collection is ideal, but a spot urine sample can confirm exposure. Levels >50 µg/L are abnormal, but acute poisoning often shows levels in the mg/L range.
- Complete Blood Count (CBC): Often reveals leukopenia and anemia. Basophilic stippling of red blood cells may be observed.
- Metabolic Panel: Assessment of renal function (BUN/Creatinine) for acute tubular necrosis and liver function tests for hepatotoxicity.
- Electrocardiogram (ECG): Mandatory to monitor for QTc prolongation, T-wave inversion, and ventricular arrhythmias (Torsades de Pointes).
- Imaging: Abdominal X-ray may occasionally show radiopaque substances if the arsenic was ingested in a solid form (e.g., arsenic trioxide).
6. Risks, Contraindications, and Management
Management Strategy
- Decontamination: Gastric lavage is only useful if performed within an hour of ingestion. Activated charcoal is generally ineffective against arsenic.
- Supportive Care: Aggressive fluid resuscitation is the cornerstone of therapy to manage hypovolemic shock and maintain renal perfusion.
- Chelation Therapy:
- Dimercaprol (BAL): The preferred chelator for acute systemic poisoning. It is administered via deep intramuscular injection.
- Dimercaptosuccinic acid (DMSA/Succimer): An oral alternative often used once the patient is stable.
- Contraindications: Do not delay chelation while awaiting laboratory results if the clinical suspicion is high.
Risks and Side Effects of Chelation
- Dimercaprol: Can cause hypertension, tachycardia, fever, and pain at the injection site. It must be used with extreme caution in patients with hepatic impairment.
7. Long-Term Prognosis
The prognosis depends entirely on the dose ingested and the speed of medical intervention. Patients who survive the initial 48-hour window of hemodynamic collapse have a higher likelihood of recovery, though long-term sequelae are common:
* Peripheral Neuropathy: A "stocking-glove" sensory-motor polyneuropathy is a common long-term complication.
* Chronic Renal Insufficiency: Due to initial acute tubular necrosis.
* Carcinogenesis: Arsenic is a known Group 1 carcinogen. Survivors carry an increased lifetime risk of skin, lung, and bladder cancers.
* Neuropsychiatric: Persistent cognitive deficits, memory loss, and emotional lability have been reported in survivors of severe poisoning.
8. Frequently Asked Questions (FAQ)
1. How quickly do symptoms appear after ingestion?
Symptoms typically manifest within 30 minutes to 4 hours, depending on the dose and the state of the stomach (full vs. empty).
2. Can arsenic poisoning be detected via hair analysis?
Hair analysis is excellent for chronic exposure, as arsenic incorporates into the hair shaft. However, it is less useful for diagnosing acute poisoning in the immediate emergency setting.
3. Is there an antidote?
Yes, Dimercaprol (BAL) is the primary antidote. It works by binding to arsenic and facilitating its excretion.
4. What is the "rice-water" stool associated with arsenic?
It refers to the appearance of the diarrheal output—profuse, watery, and containing flecks of mucus and epithelial cells, mimicking the classic presentation of cholera.
5. Why are ECG changes concerning?
Arsenic is toxic to the myocardium and can induce severe QT prolongation, which predisposes the patient to lethal arrhythmias like Torsades de Pointes.
6. Can I use activated charcoal?
Activated charcoal is generally ineffective at binding inorganic arsenic, so it is not recommended as a primary treatment.
7. Does arsenic poisoning cause permanent organ damage?
Yes, particularly to the kidneys and the peripheral nervous system. Survivors often deal with chronic nerve damage and increased cancer risk.
8. Is dermal exposure dangerous?
Yes, while less common than ingestion, significant dermal contact with concentrated arsenic compounds can lead to systemic absorption and toxicity.
9. How is the diagnosis confirmed if the patient arrives unconscious?
Diagnosis relies on a high index of suspicion, history provided by bystanders, and immediate urine toxicology screening.
10. What is the role of hemodialysis?
Hemodialysis may be indicated in patients with renal failure or to help clear the arsenic-chelator complex in cases of severe, life-threatening poisoning.
9. Conclusion
Acute arsenic poisoning is a devastating toxicological event that requires rapid recognition and aggressive intervention. As clinicians, our focus must remain on early fluid resuscitation, cardiac stabilization, and the prompt initiation of chelation therapy. While the acute phase is marked by high mortality, the long-term management of survivors requires a multidisciplinary approach, including neurology, nephrology, and oncology follow-up to address the lingering systemic effects of this potent metabolic poison. Vigilance, particularly in industrial and rural settings, remains the best defense against this lethal hazard.
Related Clinical Integration
In the management of acute arsenic poisoning, clinical focus must prioritize rapid decontamination and the initiation of appropriate chelation therapy; however, clinicians should remain vigilant regarding potential secondary complications such as hepatotoxicity or oxidative stress. While primary treatment involves specific chelating agents, supportive care protocols may necessitate the administration of N-acetylcysteine / ن-أسيتيل سيستئين Standard in cases where there is evidence of concomitant acetaminophen ingestion or as an adjunctive antioxidant therapy to mitigate systemic cellular injury. Integrating N-acetylcysteine / ن-أسيتيل سيستئين Standard into the therapeutic workflow ensures that the hospital system provides a comprehensive, multi-modal approach to stabilizing patients presenting with severe heavy metal toxicity.